Chronic Hyperkalemia in Cardiorenal Patients: Risk Factors, Diagnosis, and New Treatment Options

被引：20

作者：

Di Lullo, Luca ^{[1
]}

Ronco, Claudio ^{[2
]}

Granata, Antonio ^{[3
,4
]}

Paoletti, Ernesto ^{[5
]}

Barbera, Vincenzo ^{[1
]}

Cozzolino, Mario ^{[6
]}

Ravera, Maura ^{[5
]}

Fusaro, Maria ^{[7
]}

Bellasi, Antonio ^{[8
]}

机构：

[1] L Parodi Delfino Hosp, Dept Nephrol & Dialysis, Colleferro, Italy

[2] S Bortolo Hosp, Int Renal Res Inst, Vicenza, Italy

[3] S Giovanni di Dio Hosp, Dept Nephrol & Dialysis, Agrigento, Italy

[4] S Bortolo Hosp, Int Renal Res Inst, Vicenza, Italy

[5] San Martino Hosp, Dept Nephrol & Dialysis, Genoa, Italy

[6] S Paolo Hosp, Dept Hlth Sci, Milan, Italy

[7] Univ Padua, Dept Med, Padua, Italy

[8] St Anna Hosp, ASTT Lariana, Dept Nephrol & Dialysis, Como, Italy

来源：

CARDIORENAL MEDICINE | 2019年 / 9卷 / 01期

关键词：

Hyperkalemia; Chronic kidney disease; Heart failure; Renin-angiotensin-aldosterone system inhibitors; Potassium binder; CHRONIC KIDNEY-DISEASE; SODIUM ZIRCONIUM CYCLOSILICATE; HEART-FAILURE; SERUM POTASSIUM; RENAL-DISEASE; DOUBLE-BLIND; PATIROMER; OUTCOMES; ALDOSTERONE; ASSOCIATION;

D O I：

10.1159/000493395

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Chronic hyperkalemia (HK) is a serious medical condition that often manifests in patients with chronic kidney disease (CKD) and heart failure (HF) leading to poor outcomes and necessitating careful management by cardionephrologists. CKD, HF, diabetes, and renin-angiotensin-aldosterone system inhibitors use is known to induce HK. Current therapeutic options are not optimal, as pointed out by a large number of CKD and HF patients with HK. The following review will focus on the main risk factors for developing HK and also aims to provide a guide for a correct diagnosis and present new approaches to therapy. (C) 2018 S. Karger AG, Basel

引用

页码：8 / 21

页数：14

共 50 条

[21] Cardiorenal Interaction: Appropriate Treatment of Cardiovascular Risk Factors to Improve Outcomes in Chronic Kidney Disease
McCullough, Peter A.
Verrill, Thomas A.
POSTGRADUATE MEDICINE, 2010, 122 (02) : 25 - 34
[22] Cardiovascular calcification in chronic cardiorenal syndrome: what is the role for biomarkers in diagnosis and risk stratification?
Brandenburg, Vincent
Kruger, Thilo
LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2013, 37 (04): : 199 - 208
[23] Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink
Furuland, Hans
McEwan, Phil
Evans, Marc
Linde, Cecilia
Ayoubkhani, Daniel
Bakhai, Ameet
Palaka, Eirini
Bennett, Hayley
Qin, Lei
BMC NEPHROLOGY, 2018, 19
[24] Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics
Weir, Matthew R.
Mayo, Martha R.
Garza, Dahlia
Arthur, Susan A.
Berman, Lance
Bushinsky, David
Wilson, Daniel J.
Epstein, Murray
JOURNAL OF HYPERTENSION, 2017, 35 : S57 - S63
[25] A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient
Ash, Stephen R.
Singh, Bhupinder
Lavin, Philip T.
Stavros, Fiona
Rasmussen, Henrik S.
KIDNEY INTERNATIONAL, 2015, 88 (02) : 404 - 411
[26] Risk Factors and Frequency of Foot Ulceration in Patients Receiving Chronic Hemodialysis Treatment
Ozdemir, Vacide Asik
Nural, Nesrin
ADVANCES IN SKIN & WOUND CARE, 2024, 37 (04) : 203 - 210
[27] Potassium lowering agents: Recommendations for physician and patient education, treatment reappraisal, and serial monitoring of potassium in patients with chronic hyperkalemia
Pitt, Bertram
Rossignol, Patrick
PHARMACOLOGICAL RESEARCH, 2017, 118 : 2 - 4
[28] The Burden of Cardiovascular Risk in Chronic Kidney Disease and Dialysis Patients (Cardiorenal Syndrome Type 4)
House, Andrew A.
Ronco, Claudio
HEMODIALYSIS: NEW METHODS AND FUTURE TECHNOLOGY, 2011, 171 : 50 - 56
[29] Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
Linde, Cecilia
Bakhai, Ameet
Furuland, Hans
Evans, Marc
McEwan, Phil
Ayoubkhani, Daniel
Qin, Lei
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (22):
[30] Metabolic acidosis in neobladder patients Risk factors and treatment options
Butea-Bocu, Marius Cristian
Muller, Guido
Brock, Oliver
Otto, Ullrich
UROLOGE, 2021, 60 (05): : 617 - 623

← 1 2 3 4 5 →